Patent 9757371 was granted and assigned to Cima Labs Inc on September, 2017 by the United States Patent and Trademark Office.
Described are immediate release oral dosage forms that contain abuse-deterrent features. In particular, the disclosed dosage forms provide deterrence of abuse by ingestion of multiple individual doses. In addition, the disclosed dosage forms provide protection from overdose in the event of accidental or intentional ingestion of multiple individual doses.